In-Silico Testing & MDR: Smarter Evidence, Not Optional Evidence
Uncover the blind spots of cybersecurity, in-silico testing, and usability testing that can block CE approval or lead to costly non-conformities.
.png)
Example scenarios for Class II and Class III Devices
Class II Example
Virtual simulations for orthopedic implants can predict mechanical fatigue, wear, and stress distribution—ensuring device longevity and reliability before clinical deployment.
Class III Example
Cardiovascular devices (e.g., heart valves or stents) can be simulated to evaluate interaction with blood flow dynamics. This helps anticipate complications such as thrombosis or embolism—critical for pre-trial safety assurance.
How to successfully integrate in-silico testing into MDR compliance
To make in-silico testing count as valid evidence under MDR, manufacturers should:
- Clearly document and validate the computational models used
- Integrate results with traditional clinical and bench data in the CER
- Collaborate with notified bodies to clarify expectations and ensure alignment of computational evidence with regulatory requirements with regards to the appraisal of these in-silico trials
Regulators want traceability, transparency, and technical justification—especially for high-risk or novel devices.
Conclusion: a strategic move toward MDR compliance
In-silico testing under MDR is not just an option—it’s a smart strategic choice. It enables design decisions, faster iterations, earlier risk detection, and stronger technical files. As regulatory expectations evolve, embracing in silico testing puts you ahead of the compliance curve—while also improving patient safety and reducing reliance on traditional testing methods.
How QbD Group can support you
At QbD Group, we help medical device manufacturers integrate in-silico testing into their MDR compliance strategy. Our experts can:
- Validate and document your simulation models
- Support your CER and performance evaluation development
- Liaise with notified bodies to align your evidence with regulatory expectations
Want to explore how in silico testing can support your device strategy? Let’s talk about how we can help.
Contact us for expert guidance.
Need support with EU MDR compliance?
QbD Group combines regulatory expertise, clinical insight, and hands-on support to guide you from strategy to certification.
Partner with us to streamline your CE marking journey and bring your medical device to market with confidence.
